Acetazolamide Injection

Presentation

500 mg per vial (NDC 0143-9503-01)

Availability and Estimated Shortage Duration

This presentation is temporarily on backorder.

Related Information

Additional lots are scheduled for manufacturing and will be available in the February 2022 timeframe. Product will be made available as it is released.

Shortage Reason (per FDASIA)

Demand increase for the drug

US FDA Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Acetazolamide%20Injection&st=c&tab=tabs-1